Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 6,000 shares at $158.96 ($960K) on 2025-10-01, disclosed to the SEC on 2025-10-01.
Scheduled sale ($960k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.96 | 404 | $64K | 6.7% |
| 2 | $158.96 | 404 | $64K | 6.7% |
| 3 | $159.91 | 1,816 | $290K | 30.3% |
| 4 | $159.91 | 1,816 | $290K | 30.3% |
| 5 | $160.70 | 780 | $125K | 13.1% |
| 6 | $160.70 | 780 |
| $125K |
| 13.1% |
| Total | $159.99 avg | 6,000 | $960K | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |